Checkmate Pharmaceuticals, Inc. CMPI
10.50 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
10.49 Day range 10.50
52-week range unavailable
Valuation
P/E -1.0×
FY 2018 5y median -3.9× FY 2021
P/S 0.0×
FY 2018 5y median 0.0× FY 2021
P/B 0.9×
FY 2018 5y median 1.0× FY 2021
P/FCF -1.2×
FY 2018 5y median -4.0× FY 2021
EV/EBITDA -0.2×
FY 2018 5y median -3.3× FY 2021
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2021
FCF Yield -86.5%
FY 2018 5y median -25.3% FY 2021
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2021
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2021
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2021
ROE -88.4%
FY 2018 5y median -58.9% FY 2021
ROIC -88.4%
FY 2018 5y median -58.9% FY 2021
ROA -77.9%
FY 2018 5y median -122.2% FY 2021
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2021
Operating Income -66.4%
FY 2018 FY 2021
EPS (diluted) 26.4%
FY 2018 FY 2021
Free Cash Flow -40.9%
FY 2018 FY 2021
Financial Health
Current Ratio 7.9×
FY 2018 5y median 5.8× FY 2021
Quick Ratio 7.9×
FY 2018 5y median 5.8× FY 2021
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2021
Net Debt / EBITDA 0.8×
FY 2018 5y median 0.7× FY 2021
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2021
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2021
Annual · latest fiscal year ends 2021-12-31
